Natrium Chloratum Physiologicum Noridem (Sodium Chloride)

Sodium Chloride, the active ingredient in Natrium Chloratum Physiologicum Noridem, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular sodium and chloride levels, expand intravascular volume, and support patients with fluid loss, electrolyte imbalance, or hypovolemia.

GNH USA supplies Natrium Chloratum Physiologicum Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company ensures quality manufacturing according to EU standards and provides reliable distribution to healthcare facilities across multiple regions.

Natrium Chloratum Physiologicum Noridem is used in clinical situations that require rapid fluid and electrolyte restoration.

- Fluid replacement: restores intravascular volume and normalizes sodium and chloride concentrations in patients with dehydration or blood loss. - Electrolyte replenishment: corrects deficits of sodium and chloride in conditions such as severe diarrhea or excessive sweating. - Hypovolemia: supports circulatory stability in trauma, surgery, or shock by expanding plasma volume.

Administration of sodium chloride injection may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort or burning at the infusion site. - Hypernatremia: elevated serum sodium if administered in excess. - Fluid overload: signs of edema or pulmonary congestion in susceptible patients. - Phlebitis: inflammation of the vein used for infusion.

Serious or Rare Side Effects: - Severe hyperkalemia: rare but possible electrolyte disturbance. - Anaphylactoid reaction: unexpected hypersensitivity with rash, hypotension, or respiratory distress.

When using Natrium Chloratum Physiologicum Noridem, clinicians should observe several safety considerations.

- Patient assessment: evaluate fluid status, electrolyte levels, and cardiac function before infusion. - Infusion rate: administer slowly in patients at risk of fluid overload or cardiac compromise. - Compatibility: verify compatibility with other IV solutions or medications prior to mixing. - Monitoring: observe vital signs and serum electrolytes during and after administration. - Contraindications: avoid use in patients with known hypersensitivity to sodium chloride. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride injection can interact with certain drugs, affecting their efficacy or safety.

Major Interactions (Avoid): - Diuretics (loop or thiazide): may exacerbate electrolyte shifts, requiring close monitoring. - Hypertonic glucose solutions: concurrent use can cause rapid shifts in serum sodium, risking osmotic demyelination.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may increase risk of hypotension when combined with large volume infusions. - Blood products: co‑administration may alter electrolyte balance; monitor serum sodium.